12:00 AM
May 21, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

AutoloGel System regulatory update

The Centers for Medicare & Medicaid Services (CMS) issued a proposed decision memo supporting coverage of autologous platelet-rich plasma (PRP) gel under its coverage with evidence development (CED) mechanism to treat chronic, non-healing diabetic, venous and/or...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >